As of 2025-10-16, the Intrinsic Value of Cullinan Oncology Inc (CGEM) is -17.50 USD. This CGEM valuation is based on the model Peter Lynch Fair Value. With the current market price of 8.74 USD, the upside of Cullinan Oncology Inc is -300.25%.
Based on its market price of 8.74 USD and our intrinsic valuation, Cullinan Oncology Inc (CGEM) is overvalued by 300.25%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -17.50 - -17.50 | -17.50 | -300.25% |
| P/E | (60.00) - (76.94) | (72.72) | -932.0% |
| DDM - Stable | (19.70) - (50.72) | (35.21) | -502.8% |
| DDM - Multi | (13.55) - (28.04) | (18.36) | -310.1% |
| Market Cap (mil) | 516.27 |
| Beta | 0.80 |
| Outstanding shares (mil) | 59.07 |
| Enterprise Value (mil) | 443.45 |
| Market risk premium | 4.60% |
| Cost of Equity | 13.32% |
| Cost of Debt | 5.00% |
| WACC | 9.12% |